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Cell adhesion molecule 1 (CADM1/TSLC1/IgSF4) was
recently identified as a novel cell surface maker for adult
T-cell leukemia/lymphoma (ATLL). In this manuscript, we
developed several kinds of antibodies for diagnostic tools
identifying CADM1-positive ATLL cells. 107 kDa of
CADM1 protein was detected in the ATLL cell lines and a
72 kDa of soluble CADM1 protein was detected in serum
from ATLL patients. In analysis by flow cytometry, percen-
tages of CADM1+/CD4+ positive (DP) cells in the periph-
eral blood are well correlated with the percentages of CD4
+/CD25+ DP cells in the peripheral bloods from various
types of ATLL patients and HTLV-1 carriers. Percentages
of CADM1+/CD4+ DP cell fraction were well correlated
with the percentages of abnormal lymphocytes and DNA
copy numbers of HTLV-1 infected or ATLL cells in the
peripheral blood, particularly, with high DNA copy num-
bers of HTLV-1-infected lymphocytes from HTLV-1 car-
riers. Expression of soluble-form CADM1 is also detected
in the peripheral blood from acute-type of ATLL patients
with correlation of the level of soluble IL2Ra. Moreover,
lymphomas derived from ATLL in paraffin-embedded tis-
sue sections were strongly and specifically stained by
CADM1 antibody, suggesting that CADM1 is one of very
useful markers for identifying various types of ATLL cells.
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